We assessed the amyloidosis changes by YXQN administration, and also detected the proteases involved in the proteolytic process of APP, including ADAM10, BACE1, and PS1, in order to develop the potential Chinese medicine for AD treatment. This evidence concerns the gene APP and amyloidosis.